Halper Sadeh LLC is investigating whether certain officers and directors of TransMedics Group, Inc. breached their fiduciary duties to shareholders. Long-term TransMedics stockholders may seek corporate governance reforms, financial incentives, or other relief. The law firm offers free consultations and works on a contingent fee basis, encouraging shareholders to act quickly due to possible time limits. This investigation aims to improve company oversight and protect shareholder value.
As of Nov 13, 2026 00:32 WIB, TransMedics Group Inc (TMDX) shares trade at USD 91.91 on Pluang, showing a slight 0.11% decline over one day. The stock has a market cap of $3.20 billion and an enterprise value of $3.57 billion. Notably, all recent Pluang order activity is selling, reflecting cautious sentiment among platform investors.
TransMedics Group is reaffirmed as a strong buy due to its attractive valuation and significant growth prospects tied to expanding its multi-organ transplant platform. Key upcoming catalysts include clinical trials and European market expansion, whic...
TransMedics Group Inc. reported accelerating revenue growth, improved service margins, and increased market share in the U.S. in its recent quarter. The company raised its full-year revenue guidance to $764-774 million, expecting 24-26% organic growt...
